Apyx Medical Corp (APYX) stock
APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/3035% above fair value
$3.00+0.07 (+2.39%)
Close on Nov 11, 2026Market cap $126.37MP/E –Yield –
Apyx Medical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Apyx Medical's profit margin for the twelve months ending Sep 30, 2026 was -14.2%. For fiscal 2025 it was -21.2%, against -48.8% the year before. The highest annual figure on record is 377.7% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -21.2% | +27.6 |
| FY2024 | Dec 31, 2024 | -48.8% | −13.0 |
| FY2023 | Dec 31, 2023 | -35.7% | +16.3 |
| FY2022 | Dec 31, 2022 | -52.1% | −20.8 |
| FY2021 | Dec 31, 2021 | -31.3% | +11.7 |
| FY2020 | Dec 31, 2020 | -42.9% | +26.9 |
| FY2019 | Dec 31, 2019 | -69.8% | −447.5 |
| FY2018 | Dec 31, 2018 | 377.7% | +427.2 |
| FY2017 | Dec 31, 2017 | -49.5% | +81.5 |
| FY2016 | Dec 31, 2016 | -131.0% | −112.8 |
| FY2015 | Dec 31, 2015 | -18.2% | +44.2 |
| FY2014 | Dec 31, 2014 | -62.4% | −44.1 |
| FY2013 | Dec 31, 2013 | -18.3% | −20.6 |
| FY2012 | Dec 31, 2012 | 2.2% | +1.8 |
| FY2011 | Dec 31, 2011 | 0.4% | +6.8 |
| FY2010 | Dec 31, 2010 | -6.3% | −8.5 |
| FY2009 | Dec 31, 2009 | 2.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -12.7% | +2.7 |
| Q2 FY2026 | Jun 30, 2026 | -23.4% | +9.9 |
| Q1 FY2026 | Mar 31, 2026 | -16.9% | +27.1 |
| Q4 FY2025 | Dec 31, 2025 | -6.8% | +25.8 |
| Q3 FY2025 | Sep 30, 2025 | -15.4% | +25.5 |
| Q2 FY2025 | Jun 30, 2025 | -33.2% | +20.7 |
| Q1 FY2025 | Mar 31, 2025 | -44.0% | +29.9 |
| Q4 FY2024 | Dec 31, 2024 | -32.5% | +33.0 |
| Q3 FY2024 | Sep 30, 2024 | -40.9% | −2.3 |
| Q2 FY2024 | Jun 30, 2024 | -54.0% | −46.6 |
| Q1 FY2024 | Mar 31, 2024 | -74.0% | −45.3 |
| Q4 FY2023 | Dec 31, 2023 | -65.5% | −17.6 |
| Q3 FY2023 | Sep 30, 2023 | -38.7% | +24.6 |
| Q2 FY2023 | Jun 30, 2023 | -7.3% | +45.4 |
| Q1 FY2023 | Mar 31, 2023 | -28.7% | +18.9 |
| Q4 FY2022 | Dec 31, 2022 | -48.0% | −36.1 |
| Q3 FY2022 | Sep 30, 2022 | -63.2% | −27.6 |
| Q2 FY2022 | Jun 30, 2022 | -52.7% | −16.7 |
| Q1 FY2022 | Mar 31, 2022 | -47.6% | +9.2 |
| Q4 FY2021 | Dec 31, 2021 | -11.9% | +1.4 |
| Q3 FY2021 | Sep 30, 2021 | -35.7% | +17.9 |
| Q2 FY2021 | Jun 30, 2021 | -36.0% | +73.1 |
| Q1 FY2021 | Mar 31, 2021 | -56.7% | −17.7 |
| Q4 FY2020 | Dec 31, 2020 | -13.3% | +51.5 |
| Q3 FY2020 | Sep 30, 2020 | -53.6% | +4.1 |
| Q2 FY2020 | Jun 30, 2020 | -109.2% | −43.9 |
| Q1 FY2020 | Mar 31, 2020 | -39.0% | +60.6 |
| Q4 FY2019 | Dec 31, 2019 | -64.8% | +12.9 |
| Q3 FY2019 | Sep 30, 2019 | -57.7% | −1922.3 |
| Q2 FY2019 | Jun 30, 2019 | -65.2% | +14.4 |
| Q1 FY2019 | Mar 31, 2019 | -99.6% | −72.1 |
| Q4 FY2018 | Dec 31, 2018 | -77.7% | −55.2 |
| Q3 FY2018 | Sep 30, 2018 | 1864.6% | +1911.6 |
| Q2 FY2018 | Jun 30, 2018 | -79.6% | −23.0 |
| Q1 FY2018 | Mar 31, 2018 | -27.5% | +76.9 |
| Q4 FY2017 | Dec 31, 2017 | -22.5% | +63.0 |
| Q3 FY2017 | Sep 30, 2017 | -47.0% | – |
| Q2 FY2017 | Jun 30, 2017 | -56.6% | – |
| Q1 FY2017 | Mar 31, 2017 | -104.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -85.5% | – |
See a number that looks wrong?